Renin-Angiotensin System in Diabetes

Author(s): Johannes Rein, Michael Bader*.

Journal Name: Protein & Peptide Letters

Volume 24 , Issue 9 , 2017

Become EABM
Become Reviewer

Graphical Abstract:


Abstract:

The renin-angiotensin system (RAS) has two different axes, the classical one with the effector peptide angiotensin II and the new one with the effector peptide angiotensin (1-7). Both peptides have been shown to be involved in the pathogenesis of diabetes mellitus and its consequences, nephropathy, retinopathy and cardiomyopathy in animal models and patients. In diabetes, angiotensin II acts mostly deleterious and angiotensin (1-7) protective. In this review we summarize the knowledge about the role of the different RAS axes in diabetes mellitus and the use of drugs interfering with the RAS in the therapy of the disease.

Keywords: Renin-angiotensin system, effector peptide angiotensin, pathogenesis, diabetes mellitus, drugs, therapy.

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 24
ISSUE: 9
Year: 2017
Page: [833 - 840]
Pages: 8
DOI: 10.2174/0929866524666170728144357
Price: $58

Article Metrics

PDF: 40
HTML: 6
EPUB: 2